Charles E. Stacey
Algemeen Directeur bij Cerecin, Inc.
Profiel
Charles E.
Stacey is currently the President, Chief Executive Officer & Director at Cerecin, Inc. He has been in this position since 2015.
In terms of education, Dr. Stacey has a graduate degree from Imperial College London, an undergraduate degree from University College London, an MBA from London Business School, and a doctorate from King's College London.
Actieve functies van Charles E. Stacey
| Bedrijven | Functie | Begin |
|---|---|---|
Cerecin, Inc.
 Cerecin, Inc. Pharmaceuticals: MajorHealth Technology Cerecin, Inc. develops therapies to treat central nervous system disorders. It offers therapeutic treatments for Parkinson's disease, Alzheimer's disease, and other age-related memory loss disorders. The firm is also developing therapies that address metabolic deficiencies and provide an alternative energy source for brain cells. The company was founded in 2001 and is headquartered in Boulder, CO. | Algemeen Directeur | 01-02-2015 |
Opleiding van Charles E. Stacey
| London Business School | Masters Business Admin |
| Imperial College London | Graduate Degree |
| King's College London | Doctorate Degree |
| University College London | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 1 |
|---|---|
Cerecin, Inc.
Cerecin, Inc. Pharmaceuticals: MajorHealth Technology Cerecin, Inc. develops therapies to treat central nervous system disorders. It offers therapeutic treatments for Parkinson's disease, Alzheimer's disease, and other age-related memory loss disorders. The firm is also developing therapies that address metabolic deficiencies and provide an alternative energy source for brain cells. The company was founded in 2001 and is headquartered in Boulder, CO. | Health Technology |
